Purpose This study examined sST2, GDF-15, and galectin-3 as indicators of disease
severity and therapy response in chronic thromboembolic pulmonary hypertension …

Objective Findings regarding the prognostic value of soluble suppression of tumorigenecity-
2 (sST2) in patients with coronary artery disease (CAD) remain inconsistent. Therefore, we …

Background: The aim of the study was to assess soluble ST2 (sST2) concentration and its
dynamic changes in the periprocedural period in patients with chronic thromboembolic …

Background In a previous study, the cardio-ankle vascular index (CAVI) was increased
significantly in idiopathic pulmonary arterial hypertension (IPAH) patients compared to the …

Objectives Soluble suppression of tumorigenicity 2 (sST2) is a member of the interleukin-1
receptor family and a modulator of hypertrophic and fibrotic responses. Its prognostic value …

Objectives Pulmonary arterial hypertension (PAH) is a severe complication of CTD, being
one of the leading causes of mortality for patients with this condition. Soluble suppression of …

Background In chronic thromboembolic pulmonary hypertension, right heart failure
determines outcome. Balloon pulmonary angioplasty therapy allows right heart recovery …

Aim This study aims to evaluate the left ventricle (LV) systolic and diastolic function in
patients with idiopathic pulmonary arterial hypertension (IPAH) and its correlation with …

目的: 基于简易危险分层探索血清可溶性生长刺激表达基因2 (soluble growth stimulation
expressed gene 2, sST2) 蛋白水平在评估结缔组织病相关肺动脉高压(connective tissue …

Background Although soluble suppression of tumorigenicity-2 (sST2) has been identified as
a clinical biomarker for pulmonary hypertension (PH) by previous studies, the implication of …